New trial for people with brittle bone disease
People with a rare bone condition that can cause them to have hundreds of fractures during their lifetime are being urged to trial a new treatment.Edinburgh researchers have received £1.5m to conduct the study, which will involve 390 people with a condition called Osteogenesis Imperfecta (OI).

The six-year trial will test the combination of two therapies used to treat a different bone condition.Researchers will track the participants for up to five years.
About half of the study's participants will be treated with a drug called teriparatide followed by treatment with another drug called zoledronic acid.
The other half will receive standard care.